Knight Jeff E.
Chief Dev. & Operating Officer
Knight Jeff E. has filed 3 SEC Form 4 filings (7 transaction rows) across 1 company, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Apr 10, 2026.
On the most recent filing, Knight Jeff E. is listed as Chief Dev. & Operating Officer at Crinetics Pharmaceuticals, Inc. Inside the rolling window, Knight Jeff E. reported no open-market purchases and 2 open-market sales totaling $3.8M in CRNX. The largest disclosed transaction in the window is a sale of 85,163 CRNX shares on Apr 8, 2026, worth $3.4M.
Companies traded
Other insiders at CRNX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$3.8M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Knight Jeff E. made?
Knight Jeff E. has filed 3 SEC Form 4 filings (7 transaction rows) across 1 company since 2026.
Which companies does Knight Jeff E. trade?
Knight Jeff E. has filed SEC Form 4 disclosures for 1 company, including CRNX.
When was Knight Jeff E.'s most recent SEC Form 4 filing?
Knight Jeff E.'s most recent SEC Form 4 filing on Tracefour is dated Apr 10, 2026.
What is Knight Jeff E.'s job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Knight Jeff E. is listed as Chief Dev. & Operating Officer.
What is Knight Jeff E.'s total buy and sell value in the current window?
Inside the rolling retention window, Knight Jeff E. bought $0 and sold $3.8M based on SEC Form 4 filings.
What was Knight Jeff E.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 85,163 CRNX shares on 2026-04-08, worth $3.4M, per SEC Form 4 filings.